Mitchell P. Kopin 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 20,182 4.990% | 13,991 (+225.99%) | Filing |
| 2024-02-06 10:23 am Sale | 2023-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 6,191 6.600% | -495 (-7.40%) | Filing |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 6,686 7.600% | 279 (+4.35%) | Filing |